# Major Recall Alert: ARTEMETRIN DS (Artemether 80mg + Lumefantrine 480mg) Recalled Due to Substandard Product Levels of Artemether (59.2%) and Lumefantrine (71.2%)
Consumers in Nigeria are being alerted to a significant health risk concerning ARTEMETRIN DS (Artemether 80mg + Lumefantrine 480mg), manufactured by A.C. DRUGS Ltd. The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent recall after discovering that the medication contains only 59.2% of Artemether and 71.2% of Lumefantrine, far below the acceptable range of 90-110%. These deviations can significantly compromise the drug's efficacy in treating malaria and pose a threat to users' health. Here’s everything you need to know about this critical recall.
---
## Why This Recall is Important
Malaria remains a significant public health concern in Nigeria, and ARTEMETRIN DS, as an antimalarial drug, plays a vital role in treatment. However, a substandard product can lead to severe health repercussions, including:
- **Reduced efficacy**: Inadequate levels of active ingredients make the drug less effective in combating malaria parasites.
- **Increased risk of resistance**: Underdosing could contribute to drug-resistant strains of malaria, making treatment harder in the future.
- **Potential adverse effects**: Consumers may experience worsened symptoms or complications due to improper treatment.
For a medication like ARTEMETRIN DS to be effective, it should conform to strict pharmaceutical standards, including containing between 90-110% of its key ingredients. Falling outside these limits compromises both safety and performance.
---
## Details of the Recall
NAFDAC announced the recall for ARTEMETRIN DS on **March 30, 2025**. Key details about the product and recall include:
- **Brand**: A.C. DRUGS Ltd
- **Product**: ARTEMETRIN DS (Artemether 80mg + Lumefantrine 480mg)
- **Reason for Recall**: The product contains only **59.2% Artemether** and **71.2% Lumefantrine**, well below the regulatory standard of 90-110%.
- **Health Risks**: Use of this product could lead to treatment failures, worsened malaria symptoms, or adverse health effects.
NAFDAC has instructed all retailers, healthcare providers, and individuals to immediately stop the sale, distribution, or use of this product to prevent further health risks.
For more details, view the official NAFDAC alert here: **[NAFDAC Public Alert No. 030a/2025](https://nafdac.gov.ng/public-alert-no-030a-2025-sale-of-confirmed-substandard-artemetrin-ds-tablets/)**
---
## What You Should Do
To protect yourself and your loved ones, follow these urgent safety steps:
- **Stop usage immediately**: If you have purchased ARTEMETRIN DS, stop using the product without delay.
- **Return unused medication**: Submit any remaining stock to the nearest NAFDAC office for proper disposal.
- **Seek medical advice**: If you’ve recently taken this product and notice unusual symptoms or no improvement, consult a healthcare provider promptly.
- **Spread the word**: Inform family, friends, and your community of this recall to help others avoid potential health risks.
---
## Stay Safe – Get Instant Recall Alerts
Product recalls like this underline the importance of staying informed about health and safety announcements. Don’t let substandard products put your health at risk. Stay connected and receive instant alerts about dangerous medications by downloading NAFDAC’s free **Consumer Safety App (CSA)** today!
### Benefits of the App:
- Instant notifications for recalls and safety alerts
- Access to a verified database of safe medications
- Convenient tips to protect your health
**Download the app now** and take control of your health: *[Insert App Download Link]*
Your safety is our priority. Always double-check your medications, purchase only from approved sources, and stay informed about health updates. Together, we can ensure safer healthcare for all.
---
By raising awareness of this recall, you’re helping to protect not only yourself but countless others in your community. Stay vigilant and prioritize your safety. For more information and updates, visit the official **[NAFDAC Public Alert Page](https://nafdac.gov.ng/public-alert-no-030a-2025-sale-of-confirmed-substandard-artemetrin-ds-tablets/)**.